Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 4073.

https://doi.org/10.1182/blood.V130.Suppl_1.4073.4073

Published: 2017

Journal Articles

Results of Inter-B-NHL Ritux 2010 - Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)

G A Amos Burke, Thomas G. Gross, MD PhD, Marta Pillon, Veronique Minard-colin, Raphael F Delgado, József Zsíros, Anne Uyttebroeck, Jean Michon, Catherine M. Bollard, MD FRACP, FRCPA, Monika Csoka, Donald A Barkauskas, Keith Wheatley, DPhil, Anne Aupérin, Catherine Patte

Blood (2017) 130 (Supplement 1): 4124.

https://doi.org/10.1182/blood.V130.Suppl_1.4124.4124

Published: 2017

Journal Articles

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Conrad Russell Young Cruz, MD PhD, Sarah McCormack, BA, Kaylor Elizabeth Wright, BS, Allison B Powell, BS, Haili Lang, MS, Cecilia Barese, MDPhD, Connie Trimble, MD, Michael Keller, MD, Ephraim J. Fuchs, MD MBA, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 1923.

https://doi.org/10.1182/blood.V130.Suppl_1.1923.1923

Published: 2017

Journal Articles

Clinical Use of CMV-Specific T Cells Derived from CMV-Naïve Donors

Patrick Hanley, PhD, Michael Keller, MD, Lauren Roesch, Devin Saunders, Haili Lang, Blachy Davila, MD, Ulrich A. Duffner, MD, Divyesh Kukadiya, Fahmida Hoq, MD, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 4470.

https://doi.org/10.1182/blood.V130.Suppl_1.4470.4470

Published: 2017

Journal Articles

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Blood (2017) 130 (Supplement 1): 4516.

https://doi.org/10.1182/blood.V130.Suppl_1.4516.4516

Published: 2017

Journal Articles

Hiv Specific T Cells Generated from HIV Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT

Shabnum Patel, PhD, Shuroug Albihani, Elizabeth Williams, Julia Sung, Conrad Russell Young Cruz, MD PhD, R. Brad Jones, PhD, Elizabeth J Shpall, MD, David Margolis, Richard F Ambinder, MD, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 1010.

https://doi.org/10.1182/blood.V130.Suppl_1.1010.1010

Published: 2017

Journal Articles

Graft Versus Leukemia Response without Graft Versus Host Disease Elicited By Adoptively Transferred Multivirus-Specific T-Cells

Paul A. Castillo, MD, Jan J Melenhorst, PhD, Patrick J Hanley, PhD, Michael Keller, MD, Robert A. Krance, MD, Judith Margolin, MD, Ann Leen, PhD, Helen E. Heslop, MD, John Barrett, MD, Cliona M Rooney, PhD, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2014) 124 (21): 2439.

https://doi.org/10.1182/blood.V124.21.2439.2439

Published: 2014

Journal Articles

Natural Killer Cells In Pediatric Acute Lymphoblastic Leukemia Patients At Diagnosis Demonstrate An Inhibitory Phenotype and Reduced Cytolytic Capacity

Rayne H. Rouce, MD, Takuya Sekine, Gerrit Weber, MD, Claude Chew, Katayoun Rezvani, M.D., PhD, Catherine M. Bollard, MD, FRACP, FRCPA, Karen R Rabin, MD, PhD

Blood (2013) 122 (21): 1397.

https://doi.org/10.1182/blood.V122.21.1397.1397

Published: 2013

Journal Articles

Improving Immune Reconstitution After Cord Blood Transplantation Using Ex Vivo Expanded Virus-Specific T Cells: A Phase I Clinical Study

Patrick J Hanley, PhD, Caridad Martinez, MD, Kathryn Leung, MD, Barbara Savoldo, MD, PhD, Gianpietro Dotti, MD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Cliona M. Rooney, PhD, Helen E. Heslop, MD, Robert A. Krance, MD, Elizabeth J Shpall, MD, Catherine M. Bollard, MD, FRACP, FRCPA

Blood (2012) 120 (21): 224.

https://doi.org/10.1182/blood.V120.21.224.224

Published: 2012

Journal Articles

CD137L Reverse the Immunological Synapse Defects of Natural Killer Cells in Acute Myeloid Leukemia

Dongxia Xing, Ph. D., Alan G. Ramsay, PhD, William Decker, PhD, Dean A. Lee, MD, PhD, Simon Robinson, PhD, Nina Shah, MD, Simrit Parmar, M.D., Catherine M. Bollard, MD, FRACP, FRCPA, Chitra M Hosing, MD, Richard Champlin, MD, John G. Gribben, MD, DSc, Elizabeth J Shpall, MD

Blood (2011) 118 (21): 246.

https://doi.org/10.1182/blood.V118.21.246.246

Published: 2011

Journal Articles

The Histone Deacetylase (HDAC) Inhibitor Entinostat (SNDX-275) Targets Hodgkin Lymphoma through a Dual Mechanism of Immune Modulation and Apoptosis Induction.

Noor M Khaskhely, MD, PhD, Daniela Buglio, MD, Jessica Shafer, MD, Catherine M. Bollard, MD, FRACP, FRCPA, Anas Younes, MD

Blood (2009) 114 (22): 1562.

https://doi.org/10.1182/blood.V114.22.1562.1562

Published: 2009

Journal Articles

Dramatic Reduction of Chronic Lymphocytic Leukemia (CLL) Cells Following Adoptive Transfer of Cord Blood (CB) Natural Killer (NK) Cells Using CB-Engrafted NOD-SCID IL2Rγ null (NSG) Mice as a Model.

Dongxia Xing, PhD, Alan G. Ramsay, PhD, William Decker, PhD, Sufang Li, Simon Robinson, Ph.D., Hong Yang, PhD, Nina Shah, MD, Chitra Hosing, MD, Catherine M. Bollard, MD, FRACP, FRCPA, John G. Gribben, MD, DSc, Elizabeth J. Shpall, MD

Blood (2009) 114 (22): 2370.

https://doi.org/10.1182/blood.V114.22.2370.2370

Published: 2009

Journal Articles

Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: A 10 Year Experience.

Conrad Russell Y. Cruz, MD, Patrick Hanley, Hao Liu, PhD, Vicky Torrano, Yu-Feng Lin, Stephen Gottschalk, MD, Barbara Savoldo, MD, PhD, Gianpietro Dotti, MD, Chrystal Louis, M.D., Ann M. Leen, PhD, Cliona M. Rooney, PhD, Adrian P. Gee, PhD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Catherine M. Bollard, MD, FRACP, FRCPA, Helen E. Heslop, MD

Blood (2009) 114 (22): 3212.

https://doi.org/10.1182/blood.V114.22.3212.3212

Published: 2009

Journal Articles

Ex Vivo IL-2 Expansion of CB-NK Cells Promotes Synergistic LFA-1 and CD2 Engagement at the NK Cell Lytic Immune Synapse; Implications for Adoptive CB-NK Cell Therapy in Acute Myeloid Leukemia.

Dongxia Xing, PhD, Alan G. Ramsay, PhD, William Decker, PhD, Sufang Li, Simon Robinson, Ph.D., Hong Yang, PhD, Catherine M. Bollard, MD, FRACP, FRCPA, John G. Gribben, MD, DSc, Elizabeth J. Shpall, MD

Blood (2009) 114 (22): 3029.

https://doi.org/10.1182/blood.V114.22.3029.3029

Published: 2009

Journal Articles

Broad Spectrum Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Therapy of Hematological Malignancy.

Ulrike Gerdemann, MD, Anne S. Christin, MD, Conrad Russell Cruz, MD, Carlos A. Ramos, MD, Donald R. Shaffer, Stephen Gottschalk, MD, Helen E. Heslop, MD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Catherine M. Bollard, MD, FRACP, FRCPA, Cliona M. Rooney, PhD, Ann M. Leen, PhD

Blood (2009) 114 (22): 4083.

https://doi.org/10.1182/blood.V114.22.4083.4083

Published: 2009

Journal Articles

Immune-Based Therapies Targeting Mage-A4 for Relapsed/Refractory Hodgkin's Lymphoma After Stem Cell Transplant.

Conrad Russell Y. Cruz, MD, Ann M. Leen, PhD, Ulrike Gerdemann, MD, Anne S. Christin, MD, Tamara Tripic, PhD, Jessica Shafer, MD, Anas Younes, MD, Terzah M. Horton, MD, PhD, Elizabeth J. Shpall, MD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, Catherine M. Bollard, MD, FRACP, FRCPA

Blood (2009) 114 (22): 4089.

https://doi.org/10.1182/blood.V114.22.4089.4089

Published: 2009

Journal Articles

Cytotoxic T Lymphocytes (CTL) Specific for CMV, Adenovirus, and EBV Can Be Generated From Naive T Cells for Adoptive Immunotherapy.

Patrick Hanley, Barbara Savoldo, MD, PhD, Conrad Russell Young Cruz, MD, Ann M. Leen, PhD, Jeffrey J. Molldrem, M.D., Hao Liu, Adrian P. Gee, PhD, Helen E. Heslop, MD, Gianpietro Dotti, MD, John Rodgers, PhD, Cliona M Rooney, PhD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, Elizabeth J. Shpall, MD, Catherine M. Bollard, MD, FRACP, FRCPA

Blood (2009) 114 (22): 504.

https://doi.org/10.1182/blood.V114.22.504.504

Published: 2009

Journal Articles

Ex Vivo Expansion of Cord Blood Natural Killer Cells Overcomes Impaired Immune Synapse Formation and Effector Function in Acute Myeloid Leukemia

Dongxia Xing, PhD, Alan G Ramsay, PhD, John G. Gribben, MD, William K Decker, PhD, Jared K Burt, PhD, Sufang Li, Simon N Simon, PhD, Hong Yang, PhD, Laurence Cooper, MD, PhD, John D. McMannis, PhD, Richard E Champlin, MD, PhD, Elizabeth J Shpall, MD, Patrick Zweidler-McKay, MD, PhD, Catherine M. Bollard, MD, FRACP, FRCPA

Blood (2008) 112 (11): 2905.

https://doi.org/10.1182/blood.V112.11.2905.2905

Published: 2008

Journal Articles

The “Side-Population” of Human Lymphoma Cells Have Increased Chemo-Resistance, Stem-Cell Like Properties and Are Potential Targets for Immunotherapy

Jessica Ann Shafer, M.D., Ann M. Leen, PhD, Conrad Russell Cruz, John A Craddock, M.D., Helen E. Heslop, M.D., Cliona M. Rooney, PhD, Malcolm K Brenner, MD, PhD, Catherine M. Bollard, MD, FRACP, FRCPA, Aaron Foster, PhD

Blood (2008) 112 (11): 2620.

https://doi.org/10.1182/blood.V112.11.2620.2620

Published: 2008

NARROW

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Results of Inter-B-NHL Ritux 2010 - Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Clinical Use of CMV-Specific T Cells Derived from CMV-Naïve Donors

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Hiv Specific T Cells Generated from HIV Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT

Graft Versus Leukemia Response without Graft Versus Host Disease Elicited By Adoptively Transferred Multivirus-Specific T-Cells

Natural Killer Cells In Pediatric Acute Lymphoblastic Leukemia Patients At Diagnosis Demonstrate An Inhibitory Phenotype and Reduced Cytolytic Capacity

Improving Immune Reconstitution After Cord Blood Transplantation Using Ex Vivo Expanded Virus-Specific T Cells: A Phase I Clinical Study

CD137L Reverse the Immunological Synapse Defects of Natural Killer Cells in Acute Myeloid Leukemia

The Histone Deacetylase (HDAC) Inhibitor Entinostat (SNDX-275) Targets Hodgkin Lymphoma through a Dual Mechanism of Immune Modulation and Apoptosis Induction.

Dramatic Reduction of Chronic Lymphocytic Leukemia (CLL) Cells Following Adoptive Transfer of Cord Blood (CB) Natural Killer (NK) Cells Using CB-Engrafted NOD-SCID IL2Rγ null (NSG) Mice as a Model.

Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: A 10 Year Experience.

Ex Vivo IL-2 Expansion of CB-NK Cells Promotes Synergistic LFA-1 and CD2 Engagement at the NK Cell Lytic Immune Synapse; Implications for Adoptive CB-NK Cell Therapy in Acute Myeloid Leukemia.

Broad Spectrum Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Therapy of Hematological Malignancy.

Immune-Based Therapies Targeting Mage-A4 for Relapsed/Refractory Hodgkin's Lymphoma After Stem Cell Transplant.

Cytotoxic T Lymphocytes (CTL) Specific for CMV, Adenovirus, and EBV Can Be Generated From Naive T Cells for Adoptive Immunotherapy.

Ex Vivo Expansion of Cord Blood Natural Killer Cells Overcomes Impaired Immune Synapse Formation and Effector Function in Acute Myeloid Leukemia

The “Side-Population” of Human Lymphoma Cells Have Increased Chemo-Resistance, Stem-Cell Like Properties and Are Potential Targets for Immunotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only